Search results for " trial"

showing 10 items of 3715 documents

Efficacy of “Family Connections”, a program for relatives of people with borderline personality disorder, in the Spanish population: study protocol f…

2020

Abstract Background Patients with borderline personality disorder (BPD) experience significant affect regulation difficulties that cause serious consequences in their work, emotional, and social environments. This dysfunctional pattern also produces great suffering and a heavy burden on their relatives. Fortunately, some studies show that treatment of relatives of people with BPD begins to be important in the patients’ recovery and in improving family dynamics. One of the treatments that has obtained the most empirical support is Family connections (FC). This 12-session program is an adaptation of different Dialectical Behavior Therapy strategies. To test the efficacy of FC, five uncontroll…

relativescaregiverslcsh:RC435-571medicine.medical_treatmentDBTInterventionDysfunctional familyBurdenDialectical Behavior TherapyPersonality Disordersburdenlaw.inventionStudy ProtocolRandomized controlled triallawlcsh:PsychiatryIntervention (counseling)Family connectionsmedicineHumansBorderline personality disorderinterventionIntention-to-treat analysisbusiness.industrymedicine.diseasePersonality disordersRelativesDialectical behavior therapyClinical trialPsychiatry and Mental healthTreatment Outcomefamily connectionsCaregiversSpainBorderline personality disorderFamily Relationsbusinessborderline personality disorderClinical psychologyBMC Psychiatry
researchProduct

The McKenzie method in assessing, classifying and treating non-specific low back pain in adults with special reference to the centralization phenomen…

2010

reliabilityMcKenzie methodkipuortopedinen manipulaatiohoitofysioterapiacentralization phenomenonorthopaedic manual therapyselkäsairaudetalaselkäkipurandomized controlled trialadultsmagnetic resonance imagingselkäkuntoutusdiagnoosiMcKenzien menetelmälow back painaikuisetluokitusreliabiliteetti
researchProduct

A Systematic review to identify the effects of biologics in the feet of patients with rheumatoid arthritis

2020

Background and objective: Ninety percent of patients with rheumatoid arthritis (RA) feel foot pain during the disease process. Pharmacological treatment of RA has a systematic effect on the body and includes: Nonsteroidal anti-inflammatory drugs, disease-modifying antirheumatic drugs (DMARDs) and biologics. The objective of our review was to examine the impact of biologics on patients with RA ‘foot. Methods and material: A systematic review of randomized control trials and observational studies that evaluated the efficacy of biologics against other pharmacological treatment, and included a foot outcome measure. The search covered MEDLINE Ovid, Pubmed, CINAHL, Cochrane Library, Evidence Sear…

rheumatoid arthritismedicine.medical_specialtyMEDLINEReviewCINAHLCochrane LibraryDMARDslaw.inventionArthritis Rheumatoid03 medical and health sciences0302 clinical medicinesystematic reviewRandomized controlled triallawInternal medicineHumansMedicinebiologics030212 general & internal medicineRisk factor030203 arthritis & rheumatologylcsh:R5-920Biological ProductsArtritisbusiness.industryGeneral Medicinemedicine.diseaseNewcastle–Ottawa scaleAntirheumatic AgentsRheumatoid arthritisfeetObservational studylcsh:Medicine (General)business
researchProduct

Olive oil intake and risk of cardiovascular disease and mortality in the PREDIMED Study

2014

[Background] It is unknown whether individuals at high cardiovascular risk sustain a benefit in cardiovascular disease from increased olive oil consumption. The aim was to assess the association between total olive oil intake, its varieties (extra virgin and common olive oil) and the risk of cardiovascular disease and mortality in a Mediterranean population at high cardiovascular risk.

riesgoMediterranean diethumanosMyocardial InfarctionCardiovascularlaw.inventionCohort StudiesRandomized controlled triallawRisk FactorsNeoplasmsestudios prospectivosNutsMyocardial infarctionProspective StudiesProspective cohort studyestudios de cohortesmediana edadMedicine(all)neoplasiaseducation.field_of_studyancianodietaGeneral MedicineMiddle AgedStrokeOli d'olivaCardiovascular diseasesCardiovascular Diseasesaceites de plantasCohort studyRiskPREDIMEDmedicine.medical_specialtyPopulationenfermedades cardiovascularesNational Death IndexMediterranean dietEnvironmental healthmedicineMortalitatHumansPlant Oilsfactores de riesgoaccidente cerebrovascularMortalityeducationinfarto de miocardioAgedMediterranean DietProportional hazards modelbusiness.industryMalalties cardiovascularsmedicine.diseaseSurgeryDietnuecesbusinessOlive oil
researchProduct

Nitrate and nitrite in the diet: How to assess their benefit and risk for human health

2015

Nitrate is a natural constituent of the human diet and an approved food additive. It can be partially converted to nitrogen monoxide, which induces vasodilation and thereby decreases blood pressure. This effect is associated with a reduced risk regarding cardiovascular disease, myocardial infarction, and stroke. Moreover, dietary nitrate has been associated with beneficial effects in patients with gastric ulcer, renal failure, or metabolic syndrome. Recent studies indicate that such beneficial health effects due to dietary nitrate may be achievable at intake levels resulting from the daily consumption of nitrate-rich vegetables. N-nitroso compounds are endogenously formed in humans. However…

risk analysisNitriteischemia-reperfusion injuryPhysiologyBenefitNitric OxideToxicologyNitratereduces blood-pressureNitric oxidechemistry.chemical_compoundNitrateRisk FactorsNeoplasmsVegetablesmedicineAnimalsHumansfluke opisthorchis-viverriniNitritenih-aarp dietNitritesToxicologiecolorectal-cancer riskCarcinogenRandomized Controlled Trials as TopicVLAGNitratesChemistryN-nitroso compoundsmedicine.diseasenitrosatable drug exposureDietMeat ProductsDisease Models Animaln-nitroso compoundsBlood pressureBiochemistryNitrosationMetabolic syndromecoronary-heart-diseaseRisk assessmentBiomarkersNitroso Compoundsinorganic nitrateneural-tube defectsFood ScienceBiotechnology
researchProduct

Efficacy and safety of photodynamic therapy with RLP068 for diabetic foot ulcers: a review of the literature and clinical experience

2020

This article is the second part of a literature review concerning diabetic foot ulcers (DFUs) and the use of antimicrobial photodynamic therapy (PDT). PDT involves the topical application of a photosensitiser into the tissue, followed by illumination that induces the formation of reactive oxygen species (ROS). PDT provides bacterial inactivation and promotes wound healing, and it can be used to manage the infection and microbial colonisation of DFUs. It has pivotal advantages in comparison with chemotherapeutics, such as no potential to induce resistance, and a wide spectrum of activity. Tetracationic Zn(II) phthalocyanine derivatives have been developed for PDT. Among these, we would like …

rlp0680301 basic medicinemedicine.medical_specialtymedicine.medical_treatment030106 microbiologyPhotodynamic therapyReviewantimicrobial therapy030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineDiabetes mellitusmedicinePharmacologyulcerdiabetesbusiness.industrylcsh:RM1-950General MedicineAntimicrobialmedicine.diseaseDermatologyDiabetic footPhthalocyanine derivativesClinical triallcsh:Therapeutics. Pharmacologyphotodynamic therapyMolecular MedicineWound healingbusinessDrugs in Context
researchProduct

Immunogenicity and safety of a quadrivalent high-dose inactivated influenza vaccine compared with a standard-dose quadrivalent influenza vaccine in h…

2021

A quadrivalent high-dose inactivated influenza vaccine (IIV4-HD) is licensed for adults ≥65 y of age based on immunogenicity and efficacy studies. However, IIV4-HD has not been evaluated in adults aged 60–64 y. This study compared immunogenicity and safety of IIV4-HD with a standard-dose quadrivalent influenza vaccine (IIV4-SD) in adults aged ≥60 y. This Phase III, randomized, modified double-blind, active-controlled study enrolled 1,528 participants aged ≥60 y, randomized 1:1 to a single injection of IIV4-HD or IIV4-SD. Hemagglutination inhibition (HAI) geometric mean titers (GMTs) were measured at baseline and D 28 and seroconversion assessed. Safety was described for 180 d after vaccinat…

safetyAdultIMPACTInfluenza vaccineImmunologyimmunogenicityAntibodies ViralQuadrivalent Influenza Vaccineolder adultImmunogenicity VaccineDouble-Blind MethodInfluenza HumanMedicine and Health SciencesImmunology and AllergyMedicineHumansVaccines Combinedolder adultsPharmacologybusiness.industryImmunogenicityADULTSHemagglutination Inhibition TestsEFFICACYVirologyinfluenza vaccinationHigh-dose influenza vaccineVaccines InactivatedInfluenza VaccinesPhase III trialbusinessHuman vaccinesimmunotherapeutics
researchProduct

Safety and potential interaction of immunosuppressive drugs for the treatment of inflammatory bowel disease in elderly patients

2021

Inflammatory bowel diseases, including Crohn's disease and ulcerative colitis, are chronic diseases associated with increased morbidity and reduced quality of life. Age may represent a risk factor for adverse events, due to the multimorbidity and polypharmacy, common in elderly patients. Elderly are often not included in clinical trials evaluating efficacy and safety of study drugs for the treatment of inflammatory bowel diseases. Several drugs, such as aminosalicylates, systemic corticosteroids, immunosuppressant drugs, biological drugs and Janus Kinase inhibitors, are available for the management of inflammatory bowel diseases. With the increasing spectrum of therapeutic options, it is th…

safetyPolypharmacydrug-drug interactionsmedicine.medical_specialtybusiness.industryEndocrinology Diabetes and MetabolismInflammatory bowel disease elderly patients safety drug-drug interactionsGastroenterologyDiseaseelderly patientsmedicine.diseaseInflammatory bowel diseaseUlcerative colitisInflammatory bowel diseaseVedolizumabClinical trialUstekinumabInternal MedicinemedicineAdverse effectIntensive care medicinebusinessmedicine.drugMinerva Gastroenterology
researchProduct

Combined hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Hemophilus influenzae type b vaccine; Infanrix™ hexa: T…

2014

Infant vaccination using 2-dose priming at 3 and 5 mo of age with a booster at 11–12 mo of age was pioneered in Italy. The 3-5-11 schedule is now used in a growing number of European countries. Infanrix™ hexa (DTPa-HBV-IPV/Hib, GlaxoSmithKline Vaccines) was first licensed for use in 2000 and has been the only pediatric hexavalent vaccine available since 2005. We reviewed available clinical trial data describing the immunogenicity of DTPa-HBV-IPV/Hib when administered at 3, 5, and 11 mo of age, and conducted an analysis of safety using global and Italian post-marketing surveillance data. In Italy, DTPa-HBV-IPV/Hib has a demonstrated safety record extending over a decade of use, it has been a…

safetybooster vaccination; combination vaccines; hexavalent vaccine; immunogenicity; Italy; primary vaccination; safety; Clinical Trials as Topic; Diphtheria-Tetanus-Pertussis Vaccine; Haemophilus Vaccines; Hepatitis B Vaccines; Humans; Italy; Poliovirus Vaccine Inactivated; Product Surveillance Postmarketing; Vaccination; Vaccines Combined; Medicine (all)Settore MED/42 - Igiene Generale e ApplicataImmunologySocio-culturaleReviewimmunogenicitySettore MED/42 - Igiene Generale E Applicatamedicine.disease_causeprimary vaccinationProduct Surveillance PostmarketingmedicineImmunology and AllergyHumansHepatitis B VaccinesVaccines CombinedDiphtheria-Tetanus-Pertussis VaccineHaemophilus VaccinesPharmacologycombination vaccinesbooster vaccination; combination vaccines; hexavalent vaccine; immunogenicity; Italy; primary vaccination; safety; Medicine (all)Clinical Trials as TopicVaccinescombination vaccineTetanusbusiness.industryCombinedImmunogenicityPoliovirusDiphtheriaMedicine (all)VaccinationInactivatedHepatitis Bmedicine.diseaseVirologyProduct SurveillancePostmarketingClinical trialVaccinationPoliovirus Vaccinebooster vaccinationPoliovirus Vaccine InactivatedInfanrix hexaItalyhexavalent vaccine; primary vaccination; booster vaccination; Italy; combination vaccines; immunogenicity; safetybusinesshexavalent vaccine
researchProduct

Systematic review and meta-analysis of the efficacy and safety of minocycline in schizophrenia

2017

ObjectiveOur aim was to perform an updated systematic review and meta-analysis on the efficacy and safety of adjunctive minocycline as a treatment of schizophrenia.MethodsWe conducted a PubMed/Scopus database search from inception to 3 February 2016 for randomized, placebo-controlled trials (RCTs), open non-randomized studies, and case reports/series evaluating minocycline in patients with schizophrenia. Random-effects meta-analysis of positive, negative, depressive, and cognitive symptom rating scales, discontinuation and adverse effects rates calculating standardized mean difference (SMD), and risk ratios±95% confidence intervals (CI95%) were calculated.ResultsSix RCTs were eligible (mino…

safetymedicine.medical_specialtyefficacyMinocyclinePlacebometa-analysi03 medical and health sciences0302 clinical medicinesystematic reviewInternal medicineefficacy; meta-analysis; Minocycline; safety; schizophrenia; systematic review; Neurology (clinical); Psychiatry and Mental HealthMedicineHumansRandomized Controlled Trials as TopicPositive and Negative Syndrome Scalebusiness.industryMinocycline schizophrenia efficacy safety meta-analysis systematic reviewConfidence interval030227 psychiatryDiscontinuationAnti-Bacterial Agentsmeta-analysisschizophreniaTolerabilityStrictly standardized mean differencePsychiatry and Mental HealthMeta-analysisAdjunctive treatmentNeurology (clinical)business030217 neurology & neurosurgeryAntipsychotic Agents
researchProduct